Company & Sponsor Intelligence
Norwegian University of Science and Technology
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting1
Completed4
Countries1
Therapeutic footprint
adhddementia_otherdepressionmigraine_headacheother_psychiatrypain_neuropathy
Indexed studies
NCT00247234Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders
other_psychiatry · NorwayNA
other_psychiatry · NorwayNA
NCT03462290Botox Injections for Patients With Persistent Facial Pain
pain_neuropathy · NorwayPHASE2
pain_neuropathy · NorwayPHASE2
NCT04010851The Effects of a Peer Co-led Educational Programme for Parents of Children With ADHD
adhd · NA
adhd · NA
NCT02019017Botox Injection in Treatment of Cluster Headache
migraine_headache · NorwayPHASE1, PHASE2
migraine_headache · NorwayPHASE1, PHASE2
NCT04541056Goal Management Training for Adult Survivors of Childhood Leukemia and Non-Hodgkins Lymphoma With Neurocognitive Sequelae
dementia_other · NorwayNA
dementia_other · NorwayNA
NCT00972634Computerized Questionnaires in Assessing Symptoms, Pain, Depression, and Physical Function in Patients With Metastatic and/or Advanced Locoregional Cancer
depression · NorwayCOMPLETED
depression · NorwayCOMPLETED
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →